News | January 12, 2010

Endothelial Function Test Named a Top Medical Breakthrough

January 12, 2010 – In its January issue, Prevention magazine named the Endo-PAT2000 endothelial function testing device one of the top medical breakthroughs of 2009.

The American Heart Association said 50 percent of coronary deaths occur in people with no previous symptoms, but a study by the Mayo Clinic suggests measuring endothelial function can aid diagnosis. The seven-year Mayo Clinic and Tufts-New England Medical Center study published in April 2009 found the measuring vessel health can help diagnosis a variety of medical conditions, including coronary artery disease, heart attack, stroke, sleep apnea, pre-eclamptic toxemia, and erectile dysfunction.

The study suggests a patient with low risk (based on Framingham Risk Score) but high endothelial dysfunction is 300 percent more likely to have a heart attack than a patient with low risk and no endothelial dysfunction. In the study, 49 percent of patients whose Endo-PAT test indicated poor endothelial function had a cardiac event during the seven-year study.

Amir Lerman, M.D., a cardiologist at the Mayo Clinic, explained that a “poor score is a stronger warning than the usual risk factors, because it indicates that cardiovascular disease has already begun – but at an early stage when you can more easily control your risks.”

The medical technology company Medvica International is among the first companies to market the Endo-PAT2000 in North America. The device uses sensors that measure blood flow through a patient’s fingers. Endothelial cells line the inner walls of blood vessels, lymph vessels, and the heart, and damage to them may be an early sign of heart disease. The device is small enough to sit on a table for office-based use. The test takes 15-minutes.

Endo-PAT testing is reimbursable by Medicare and covered by most major U.S. insurance companies.

For more information: www.medvica.com

Related Content

Male Triathletes May Be Putting Their Heart Health at Risk
News | Cardiac Diagnostics| January 09, 2018
Competitive male triathletes face a higher risk of a potentially harmful heart condition called myocardial fibrosis,...
ERT Acquires iCardiac Technologies
News | Cardiac Diagnostics| December 19, 2017
ERT recently announced it has acquired iCardiac Technologies, a provider of centralized cardiac safety and respiratory...
New Study Suggests Protein Could Protect Against Coronary Artery Disease

Patients with no obstructed blood flow in the coronary arteries had higher levels of CXCL5 (blue) compared to patients with moderate levels (green) or lower levels (yellow) of CXCL5, who had increased severity of coronary obstructions (indicated by the arrows). Credit: Schisler lab

News | Cardiac Diagnostics| December 07, 2017
December 7, 2017 — The buildup of plaque in the heart’s arteries is an unfortunate part of aging.
E-cigarettes Most Likely to be Used by Alcohol Drinkers and Former Cigarette Smokers, at American Heart Association (AHA), #AHA2017.
News | Cardiac Diagnostics| December 06, 2017
December 6, 2017 — Electronic cigarettes are more frequently used by people who recently quit smoking and alcohol dri
Lack of sleep may cause heart disease in older women. American heart Association, #AHA2017
News | Cardiac Diagnostics| December 06, 2017
December 6, 2017 — Older women who do not get enough sleep were more likely to have poor cardiovascular health, accor
New Tool Predicts Risk of Heart Attack in Older Surgery Patients
News | Cardiac Diagnostics| December 05, 2017
A tool designed to more accurately predict the risk of heart attack in older patients undergoing non-cardiac surgery...
EPIC Norfolk prospective population study showed any physical activity is better than none in older adults in preventing cardiovascular disease.

The EPIC Norfolk prospective population study showed any physical activity is better than none in older adults in preventing cardiovascular disease.

News | Cardiac Diagnostics| November 24, 2017
November 24, 2017 — Any physical activity in the elderly is better than none at all for reducing cardiovascular risk,
Analytics 4 Life Presents Clinical Data on Machine-Learned Cardiac Imaging Technology at TCT 2017
News | Cardiac Diagnostics| November 01, 2017
Analytics 4 Life announced it will be presenting new clinical data on the company's ongoing Coronary Artery Disease...
American Heart Association, Verily and AstraZeneca Launch One Brave Idea Science Innovation Center
News | Cardiac Diagnostics| October 20, 2017
The American Heart Association, Verily and AstraZeneca announced the opening of the One Brave Idea Science Innovation...
The Role of Telomere Length in Cardiovascular Risk Assessment
Feature | Cardiac Diagnostics| October 19, 2017 | Nanette H. Bishopric, M.D., FACC, FAHA
A new area of DNA testing involving telomere length may enhance a patient’s cardiovascular disease risk stratificatio
Overlay Init